Characterization of Vemurafenib-Resistant Melanoma Cell Lines Reveals Novel Hallmarks of Targeted Therapy Resistance.
International Journal Of Molecular Sciences
Radić, Martina M; Vlašić, Ignacija I; Jazvinšćak Jembrek, Maja M; Horvat, Anđela A; Tadijan, Ana A; Sabol, Maja M; Dužević, Marko M; Herak Bosnar, Maja M; Slade, Neda N
EV20-Sap, a novel anti-HER-3 antibody-drug conjugate, displays promising antitumor activity in melanoma.
Oncotarget
Capone, Emily E; Giansanti, Francesco F; Ponziani, Sara S; Lamolinara, Alessia A; Iezzi, Manuela M; Cimini, Annamaria A; Angelucci, Francesco F; Sorda, Rossana La R; Laurenzi, Vincenzo De V; Natali, Pier Giorgio PG; Ippoliti, Rodolfo R; Iacobelli, Stefano S; Sala, Gianluca G
AP2α controls the dynamic balance between miR-126&126* and miR-221&222 during melanoma progression.
Oncogene
Felli, N N; Errico, M C MC; Pedini, F F; Petrini, M M; Puglisi, R R; Bellenghi, M M; Boe, A A; Felicetti, F F; Mattia, G G; De Feo, A A; Bottero, L L; Tripodo, C C; Carè, A A